149 related articles for article (PubMed ID: 37101062)
1. Unambiguous radiologic extranodal extension determined by MRI could be a biomarker in predicting metastatic prostate cancer.
Han Y; Shen F; Jiao J; Xiao Z; Qin W; Ren J; Huan Y
Radiol Med; 2023 May; 128(5):520-527. PubMed ID: 37101062
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.
Lenis AT; Pooli A; Lec PM; Sadun TY; Johnson DC; Lebacle C; Fendler WP; Eiber M; Czernin J; Reiter RE; Calais J
Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451
[TBL] [Abstract][Full Text] [Related]
4. Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
Mao Y; Wang S; Lydiatt W; Shah JP; Colevas AD; Lee AWM; O'Sullivan B; Guo R; Luo W; Chen Y; Tian L; Tang L; Sun Y; Liu L; Ren J; Ma J
Radiother Oncol; 2021 Apr; 157():114-121. PubMed ID: 33516790
[TBL] [Abstract][Full Text] [Related]
5. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
7. Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance.
Jang S; Lee S; Chung JH; Lee KW; Lee KH
AJR Am J Roentgenol; 2023 Oct; 221(4):471-484. PubMed ID: 37255045
[No Abstract] [Full Text] [Related]
8.
Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
[TBL] [Abstract][Full Text] [Related]
9.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
10. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract][Full Text] [Related]
11. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A; Yu E; Su J; O'Sullivan B; Waldron J; Ringash J; Bartlett E; Perez-Ordonez B; Weinreb I; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Hansen AR; de Almeida J; Tong L; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1017-1027. PubMed ID: 30953712
[TBL] [Abstract][Full Text] [Related]
12. The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.
Hu YJ; Lu TZ; Guo QJ; Zhang L; Xiao YP; Lin SJ; Zhou H; Zheng DC; Ding SR; Liu LZ; Gong XC; Li JG; Pan JJ; Xia YF
Radiother Oncol; 2023 Jan; 178():109436. PubMed ID: 36464180
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
Fan KH; Yeh CH; Hung SP; Kang CJ; Huang SF; Chang KP; Wang HM; Chia-Hsun Hsieh J; Lin CY; Cheng AJ; Ng SH; Tung-Chieh Chang J
Radiother Oncol; 2021 Mar; 156():217-222. PubMed ID: 33385465
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
Tsai TY; Chou YC; Lu YA; Kang CJ; Huang SF; Liao CT; Chang KP
Oral Oncol; 2021 Nov; 122():105518. PubMed ID: 34507205
[TBL] [Abstract][Full Text] [Related]
15. Primary staging in patients with intermediate- and high-risk prostate cancer: Multiparametric MRI and
Skawran SM; Sanchez V; Ghafoor S; Hötker AM; Burger IA; Huellner MW; Eberli D; Donati OF
Eur J Radiol; 2022 Jan; 146():110044. PubMed ID: 34844173
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study.
Donswijk ML; van Leeuwen PJ; Vegt E; Cheung Z; Heijmink SWTPJ; van der Poel HG; Stokkel MPM
BMC Cancer; 2020 Aug; 20(1):723. PubMed ID: 32758168
[TBL] [Abstract][Full Text] [Related]
17. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
Kulkarni SC; Sundaram PS; Padma S
Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
[TBL] [Abstract][Full Text] [Related]
18. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
Abrams-Pompe RS; Fanti S; Schoots IG; Moore CM; Turkbey B; Vickers AJ; Walz J; Steuber T; Eastham JA
Eur Urol Oncol; 2021 Jun; 4(3):370-395. PubMed ID: 33272865
[TBL] [Abstract][Full Text] [Related]
19. Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer.
Giesel FL; Sterzing F; Schlemmer HP; Holland-Letz T; Mier W; Rius M; Afshar-Oromieh A; Kopka K; Debus J; Haberkorn U; Kratochwil C
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1400-6. PubMed ID: 26971788
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
